晚期乳腺癌介入诊疗的价值及应用

doi:10.16139/j.1007-9610.2022.05.007

摘要/Abstract

中图分类号:

R737.9
R815

黄蔚, 李恒宇, 丁晓毅. 晚期乳腺癌介入诊疗的价值及应用[J]. 外科理论与实践, 2022, 27(05): 411-415.

HUANG Wei, Ll Hengyu, DING Xiaoyi. Value and application of intervention in advanced breast cancer[J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 411-415.

参考文献 39

[1]	Cardoso F, Paluch-Shimon S, Senkus E, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer(ABC 5)[J]. Ann Oncol, 2020, 31(12):1623-1649.
[2]	Cardoso F, Spence D, Mertz S, et al. Global analysis of advanced/metastatic breast cancer: decade report (2005-2015)[J]. Breast, 2018, 39:131-138.
[3]	Pagani O, Senkus E, Wood W, et al. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?[J]. J Natl Cancer Inst, 2010, 102(7):456-463.
[4]	林雪芳, 林添钰, 丘建燊, 等. 肺占位穿刺基于CT评估肺出血风险的临床研究[J]. 临床肺科杂志, 2022, 27(3):370-375.
[5]	Matsuura K, Itamoto T, Noma M, et al. Significance of lung biopsy for the definitive diagnosis of lung nodules in breast cancer patients[J]. Mol Clin Oncol, 2018, 8(2):250-256.
[6]	Beji H, Pilleul F, Picard R, et al. Percutaneous cryoablation of breast tumours in patients with stable metastatic breast cancer: safety, feasibility and efficacy[J]. Br J Radiol, 2018, 91(1083):20170500.
[7]	Brkljacic B, Cikara I, Ivanac G, et al. Ultrasound-guided bipolar radiofrequency ablation of breast cancer in in-operable patients: a pilot study[J]. Ultraschall Med, 2010, 31(2):156-162.
[8]	杨小青, 秦春新, 周少杰. 局部晚期乳腺癌的微波消融治疗[J]. 局解手术学杂志, 2018, 27(11):845-847.
[9]	Neal RE 2nd, Singh R, Hatcher HC, et al. Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode[J]. Breast Cancer Res Treat, 2010, 123(1):295-301.
[10]	Roknsharifi S, Wattamwar K, Fishman MDC, et al. Image-guided microinvasive percutaneous treatment of breast lesions: where do we stand?[J]. Radiographics, 2021, 41(4):945-966.
[11]	Ma J, Song J, Chen H, et al. Intra-arterial interventional therapy for inoperable local advanced breast cancer: a retrospective study[J]. Oncol Lett, 2018, 15(2):1955-1962.
[12]	Wang X, Gan C, Li H, et al. Main complications and results of treatment with intra-arterial infusion chemotherapy through the subclavian and thoracic arteries for locally advanced breast cancer[J]. Mol Clin Oncol, 2013, 1(4):745-748.
[13]	许彪, 庄亚强, 刘惕生, 等. 多支超选择性动脉化疗联合手术治疗中晚期乳腺癌[J]. 实用放射学杂志, 2011, 27(6):925-928.
[14]	周韬, 庄亚强, 许彪, 等. DSA下多支超选择性动脉灌注化疗联合手术治疗中晚期乳腺癌的临床疗效分析[J]. 现代肿瘤医学, 2012, 20(7):1363-1366.
[15]	Guirguis MS, Checka C, Adrada BE, et al. Bracketing with multiple radioactive seeds to achieve negative margins in breast conservation surgery: multiple seeds in breast surgery[J]. Clin Breast Cancer, 2022, 22(2):e158-e166.
[16]	de Campos TP, Nogueira LB, Trindade B, et al. Dosime-tric intercomparison of permanent Ho-166 seed′s implants and HDR Ir-192 brachytherapy in breast cancer[J]. Rep Pract Oncol Radiother, 2016, 21(3):240-249.
[17]	Barral M, Auperin A, Hakime A, et al. Percutaneous thermal ablation of breast cancer metastases in oligometastatic patients[J]. Cardiovasc Intervent Radiol, 2016, 39(6):885-893.
[18]	Kent CL, McDuff SGR, Salama JK. Oligometastatic breast cancer: where are we now and where are we headed?—a narrative review[J]. Ann Palliat Med, 2021, 10(5):5954-5968.
[19]	Kwapisz D. Oligometastatic breast cancer[J]. Breast Cancer, 2019, 26(2):138-146.
[20]	Ridouani F, Solomon SB, Bryce Y, et al. Predictors of progression-free survival and local tumor control after percutaneous thermal ablation of oligometastatic breast cancer: retrospective study[J]. J Vasc Interv Radiol, 2020, 31(8):1201-1209.
[21]	AlSendi M, O′Reilly D, Zeidan YH, et al. Oligometastatic breast cancer: are we there yet?[J]. Int J Cancer, 2021, 149(8):1520-1528.
[22]	Kobayashi T, Ichiba T, Sakuyama T, et al. Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review[J]. Breast Cancer, 2012, 19(3):218-237.
[23]	Tewes M, Peis MW, Bogner S, et al. Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: effcacy, safety and prognostic parameters[J]. J Cancer Res Clin Oncol, 2017, 143(10):2131-2141.
[24]	Aarts BM, Klompenhouwer EG, Dresen RC, et al. Intra-arterial mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival[J]. Breast Cancer Res Treat, 2019, 176(3):597-605.
[25]	Firmino F, Villela-Castro DL, Santos JD, et al. Topical management of bleeding from malignant wounds caused by breast cancer: a systematic review[J]. J Pain Symptom Manage, 2021, 61(6):1278-1286.
[26]	Firmino F, Santos J, Meira KC, et al. Regenerated oxidised cellulose versus calcium alginate in controlling bleeding from malignant breast cancer wounds: randomised control trial study protocol[J]. J Wound Care, 2020, 29(1):52-60.
[27]	Kitayama K, Ozaki M, Ninoi T, et al. A case of effective endovascular treatment for recurrent bleeding from advanced breast cancer[J]. Gan To Kagaku Ryoho, 2020, 47(13):2394-2396.
[28]	Ledys F, Kalfeist L, Galland L, et al. Therapeutic associa-tions comprising anti-PD-1/PD-L1 in breast cancer: clinical challenges and perspectives[J]. Cancers (Basel), 2021, 13(23):5999.
[29]	Guo X, Du F, Liu Q, et al. Immunological effect of irreversible electroporation on hepatocellular carcinoma[J]. BMC Cancer, 2021, 21(1):443.
[30]	Li J, Liu F, Gupta S, et al. Interventional nanotheranostics of pancreatic ductal adenocarcinoma[J]. Theranostics, 2016, 15, 6(9):1393-1402.
[31]	陈艳军, 程冰冰, 郜宇, 等. 纳米刀消融治疗局部进展期胰腺癌的免疫机制研究[J]. 医药论坛杂志, 2021, 42(4):1-6,11.
[32]	Ringel-Scaia VM, Beitel-White N, Lorenzo MF, et al. High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity[J]. EBioMedicine, 2019, 44:112-125.
[33]	Shao Q, O′Flanagan S, Lam T, et al. Engineering T cell response to cancer antigens by choice of focal therapeutic conditions[J]. Int J Hyperthermia, 2019, 36(1):130-138.
[34]	He C, Huang X, Zhang Y, et al. T-cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer[J]. Clin Transl Med, 2020, 10(2):e39.
[35]	Dai Z, Wang Z, Lei K, et al. Irreversible electroporation induces CD8⁺ T cell immune response against post-ablation hepatocellular carcinoma growth[J]. Cancer Lett, 2021, 503:1-10.
[36]	Scheffer HJ, Stam AGM, Geboers B, et al. Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation[J]. Oncoimmunology, 2019, 8(11):1652532.
[37]	Beitel-White N, Martin RCG, Li Y, et al. Real-time prediction of patient immune cell modulation during irreversible electroporation therapy[J]. Sci Rep, 2019, 9(1):17739.
[38]	Holgado E, Perez-Garcia J, Gion M, et al. Is there a role for immunotherapy in HER2-positive breast cancer?[J]. NPJ Breast Cancer, 2018, 4:21.
[39]	Zhao J, Wen X, Tian L, et al. Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer[J]. Nat Commun, 2019, 10(1):899.

晚期乳腺癌介入诊疗的价值及应用

Value and application of intervention in advanced breast cancer

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 39

相关文章 15

编辑推荐

Metrics

本文评价

[1]	徐康倪　袁斯明. 婴幼儿血管瘤的局部医源性并发症 [J]. 组织工程与重建外科杂志, 2023, 19(2): 146-.
[2]	侯森林, 于廷廷, 刘鹏翔, 张立超. 超声内镜介入治疗在胆胰疾病中的应用[J]. 外科理论与实践, 2023, 28(04): 300-306.
[3]	叶枫, 龚笑勇, 任家俊, 蔡强, 陈胜. ERCP在原发性肝癌围术期胆道并发症诊治中的应用[J]. 外科理论与实践, 2023, 28(04): 355-360.
[4]	于岚, 张永怡, 黄雷, 万歆, 姜胜耀, 唐思静, 张俊, 胡伟国. 老年病人胰十二指肠切除术后严重并发症发生的危险因素[J]. 外科理论与实践, 2023, 28(02): 139-146.
[5]	华晴, 周建桥. 甲状腺良性结节超声引导下热消融并发症研究进展[J]. 诊断学理论与实践, 2023, 22(02): 184-189.
[6]	何凯, 唐颖, 周秀玲, 朱俞岚, 傅晓键, 朱炎逢, 丁红, 姚琪远, 陈浩. 腔镜腹白线折叠缝合术治疗产伤性腹直肌分离的临床疗效评估[J]. 外科理论与实践, 2023, 28(01): 67-71.
[7]	宋达疆　李赞　章一新. 带蒂腹直肌皮瓣联合游离腹壁下动脉穿支皮瓣移植重建胸壁巨大缺损的手术策略[J]. 组织工程与重建外科杂志, 2022, 18(5): 386-.
[8]	李建锋　李强　黄欢　张希峰　严建锋　蔡莉丹. 高龄患者髋关节置换的ERAS路径与传统路径的临床疗效对比[J]. 组织工程与重建外科杂志, 2022, 18(2): 154-.
[9]	庄奥博, 童汉兴, 张勇, 陆维祺, 周宇红, 闾晨涛. 老年原发性腹膜后软组织肉瘤病人手术治疗安全性分析的回顾性队列研究[J]. 外科理论与实践, 2022, 27(06): 534-539.
[10]	王瑞华, 仇鹏, 刘俊超, 吴小雨, 秦金保, 叶开创, 李维敏, 刘晓兵, 殷敏毅, 黄新天, 陆信武. 激光原位开窗胸主动脉腔内重建治疗累及弓部分支的主动脉夹层:近期结果及并发症[J]. 外科理论与实践, 2022, 27(04): 324-329.
[11]	杜燕然, 焦景, 任芸芸, 周建桥. 超声影像组学技术在评估胎肺成熟度中的应用[J]. 诊断学理论与实践, 2022, 21(03): 326-330.
[12]	胡健, 杨震坤, 闫小响, 杜润, 丁风华, 刘俊. 经皮冠状动脉介入术和冠状动脉旁路移植术对80岁以上左前支慢性闭塞患者的疗效比较[J]. 内科理论与实践, 2022, 17(01): 70-72.
[13]	王巍, 华杰. 胰十二指肠切除术中常见血管变异及应对策略[J]. 外科理论与实践, 2022, 27(01): 34-38.
[14]	林喜风卢艺朴王涛. 微创钥匙孔负压抽吸术治疗腋臭疗效观察及术后并发症影响因素分析[J]. 组织工程与重建外科杂志, 2021, 17(4): 335-.
[15]	李艳李萍殷宗宝陈晓峰薛小云张烨. 急性髋关节骨折患者手术时机的选择[J]. 组织工程与重建外科杂志, 2021, 17(4): 345-.